Although we have found evidence to support FLT-PET imaging in the evaluation of the arginine-ASS1-ADI pathway in thoracic cancers (especially MPM), the small sample size, high dropout, wide confidence intervals, and barely significant p values suggest that further evaluation is warranted. Here, ASS1 is linked to thoracic cancer.